We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
IMPLANON NXT, JULESTREL, LARCPLANON ORGANON PHARMA PTY LTD
Product name
IMPLANON NXT, JULESTREL, LARCPLANON
Sponsor
Accepted date
Oct-2025
Active ingredients
etonogestrel
Summary of proposed indication
Implanon/Julestrel/Larcplanon (etonogestrel) is proposed for contraception. The implant is to be removed and replaced every five years to ensure continued contraceptive effectiveness.
Application type
C (new indication)
Publication date
Oct-2025